Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

A new lead in treating chronic social defeat stress

Published on: 24/05/2017 Reading time: 1 min
Une personne en dépression
Retour à la recherche

24Chronic social defeat stress is a cause in many cases of depression. In humans, chronic social stress is built over time based on our past social interaction, with numerous consequences on both a psychological and neurological level.

Beyond depression, many patients display cognitive disorders including memory and attention loss, and complicated decision-making. Current therapy is focused on treating depression, yet its impact on cognitive deficiency remains unclear.

Institut du Cerveau - ICM researchers focused on the behavioral and molecular impact of chronic social defeat stress in an experimental model summarizing similar symptoms to those observed in humans. They also studied the effect of a molecule named agomelatine that has demonstrated antidepressant and anxiolytic effects.

In addition to behavioral modifications and memory disorders observed in animals, researchers highlighted a decrease in the expression of certain genes of the hippocampus, an area of the brain that plays a crucial role in memory and known to be directly affected in social stress. Results showed that agomelatine has an effect on cognitive disorders and gene expression in the hippocampus.

This data suggests that agomelatine may be of particular interest in treating cognitive disorders associated with depression. Complementary studies will focus on studying the molecule’s mechanisms.

Sources

Effect of agomelatine on memory deficits and hippocampal gene expression induced by chronic social defeat stress in mice.
https://www.nature.com/articles/srep45907
Martin V, Allaïli N, Euvrard M, Marday T, Riffaud A, Franc B, Mocaër E, Gabriel C, Fossati P, Lehericy S, Lanfumey L. Sci Rep. 2017 Apr 4;8:45907

Our news on the subject

L’IRM structurelle ne permet pas, à elle seule, de diagnostiquer la dépression
Structural MRI alone cannot diagnose depression
Can brain imaging reveal whether a person is affected by depression? This question has driven research for many years. Changes in brain structure have indeed been observed in patients with depression, suggesting that structural MRI might one day help...
03.12.2026 Research, science & health
Épilepsie temporale : une nouvelle stratégie pour corriger l’activité électrique anormale
Temporal Lobe Epilepsy: A New Strategy to Correct Abnormal Electrical Activity
Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are eligible for the procedure. For these individuals...
03.06.2026 Research, science & health
Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
See all our news